Billets de Michelle Dawson

Billet publié sur Twitter/X le 02/12/2020 08:21

Twitter/X Publication avec DOI crossref Extrait cité dans le billet Lien intégré au billet

Liens cités structurés

1 ressource citée

Publication avec DOI Récupéré Publication crossref

Bradley S. Peterson (2020). Editorial: Biomarkers in precision medicine for mental illnesses. Journal of Child Psychology and Psychiatry, 61(12), 1279-1281. Wiley.

Date de publication
30/11/2020
Identifiant
10.1111/jcpp.13357
Auteurs
Bradley S. Peterson
Source
Journal of Child Psychology and Psychiatry
Détails
61(12), 1279-1281
Type de référence
article
Éditeur
Wiley
Source de métadonnées
crossref

Résumé

Precision medicine and biomarker development have become the prevailing paradigm for mental health research. Despite its conceptual elegance and dominance as a research framework, precision medicine has a very limited track record of demonstrable success thus far for mental illnesses, due in varying degrees to the complexity of both the brain and the pathophysiology of mental illnesses, which limits our ability to develop, replicate, and validate biomarkers for use in enhancing clinical care for mental illnesses, especially in high‐risk and complex clinical populations. Research and funding priorities should integrate biomarker development and precision medicine interventions that target the robust behavioral, environmental, and social determinants that we know are important for population‐based mental health.

Auteur·ices de l’étude dans cette référence citée